Buck E Rogers Selected Research

Buck E Rogers Research Topics

Disease

46	Neoplasms (Cancer) 06/2022 - 02/2002
12	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 07/2003
6	Alzheimer Disease (Alzheimer's Disease) 03/2022 - 01/2017
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 03/2012
4	Amyloid Plaque 06/2022 - 01/2017
3	Glioblastoma (Glioblastoma Multiforme) 11/2020 - 04/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2019
2	Fibrosis (Cirrhosis) 01/2021 - 01/2021
2	Breast Neoplasms (Breast Cancer) 06/2018 - 01/2007
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018 - 07/2014
2	Colorectal Neoplasms (Colorectal Cancer) 09/2013 - 02/2012
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 06/2022
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Ventricular Tachycardia 01/2021
1	Heart Failure 01/2021
1	Starvation 12/2020
1	Inflammation (Inflammations) 11/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Adenocarcinoma 01/2019
1	Infections 01/2019
1	Bacterial Infections (Bacterial Infection) 09/2017
1	Glioma (Gliomas) 12/2016
1	Ovarian Neoplasms (Ovarian Cancer) 01/2014

Drug/Important Bio-Agent (IBA)

16	Peptides (Polypeptides)IBA 06/2022 - 02/2002
12	BombesinIBA 06/2022 - 07/2003
9	LigandsIBA 06/2022 - 01/2008
9	Bombesin Receptors (Bombesin Receptor)IBA 06/2022 - 07/2003
5	Chelating AgentsIBA 03/2022 - 04/2003
5	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2022 - 07/2007
5	Somatostatin Receptors (Somatostatin Receptor)IBA 07/2014 - 02/2002
4	Radioisotopes (Radionuclides)IBA 06/2022 - 07/2007
3	Amyloid (Amyloid Fibrils)IBA 06/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 12/2020 - 03/2012
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2013
3	RadiopharmaceuticalsIBA 01/2017 - 01/2007
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2012 - 05/2002
2	CopperIBA 06/2022 - 09/2017
2	IntegrinsIBA 01/2022 - 07/2018
2	Chemokine ReceptorsIBA 01/2021 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2019
2	Amyloid beta-PeptidesIBA 12/2020 - 01/2017
2	Copper-64IBA 07/2020 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 12/2016 - 01/2014
2	Gastrin-Releasing PeptideIBA 04/2016 - 02/2015
2	ErbB Receptors (EGF Receptor)IBA 09/2013 - 03/2004
2	Monoclonal AntibodiesIBA 10/2005 - 04/2003
1	benzothiazoleIBA 06/2022
1	EstersIBA 01/2022
1	2-(4-hydroxyphenyl)benzothiazoleIBA 01/2022
1	talazoparibIBA 05/2021
1	VaccinesIBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	distyrylbenzeneIBA 01/2021
1	pirfenidoneIBA 01/2021
1	Mutant Proteins (Protein, Mutant)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Immunoglobulin FragmentsIBA 01/2021
1	GlutaminaseIBA 12/2020
1	Glutamine (L-Glutamine)FDA Link 12/2020
1	Sulfhydryl Compounds (Thiols)IBA 12/2020
1	Purine NucleosidesIBA 11/2020
1	TritiumIBA 11/2020
1	Nudix HydrolasesIBA 11/2020
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 11/2020
1	Phosphotransferases (Kinase)IBA 11/2020
1	Adenosine Diphosphate (ADP)IBA 11/2020
1	sphingosine kinaseIBA 11/2020
1	Biological ProductsIBA 11/2020
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2020
1	NADP (NADPH)IBA 01/2020
1	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	beta-lapachoneIBA 01/2020
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2018
1	Poly (ADP-Ribose) Polymerase-1IBA 11/2018
1	olaparibIBA 11/2018
1	Trastuzumab (Herceptin)FDA Link 06/2018
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2018
1	peptide AIBA 12/2016
1	Endoplasmic Reticulum Chaperone BiPIBA 12/2016
1	Peptide Receptors (Peptide Receptor)IBA 04/2016
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2016
1	phosphoramidonIBA 04/2016
1	Transferrin (beta 2 Transferrin)IBA 01/2016
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2016
1	Neuropeptide Receptors (Neuropeptide Receptor)IBA 02/2015
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2014

Therapy/Procedure

18	Therapeutics 06/2022 - 02/2002
7	Radiotherapy 05/2021 - 02/2002
3	Intravenous Injections 07/2018 - 02/2002
2	Precision Medicine 06/2022 - 07/2018
2	Immunotherapy 01/2021 - 01/2019
1	Drug Therapy (Chemotherapy) 01/2020
1	Aftercare (After-Treatment) 01/2020